Summary To study whether colony growth in vitro reflects the prognosis of breast cancer patients, specimens from a total number of 138 patients with primary breast carcinomas were cultivated in the Courtenay-Mills soft agar method. The plating efficiency (PE) In spite of intense efforts limited progress has been made in recent years in the treatment of patients with breast carcinoma and in most cases the long-term prognosis is still poor.
In spite of intense efforts limited progress has been made in recent years in the treatment of patients with breast carcinoma and in most cases the long-term prognosis is still poor.
In efforts to improve therapy it is important to identify prognostic factors defining subgroups of patients that might benefit from special treatment schedules. It is well established that the prognosis of breast cancer is clearly related to the number of affected lymph nodes (Nemoto et al., 1980) , the tumour size (Fisher et al., 1969) and the oestrogen receptor level in the tumour (Hahnel et al., 1979) . Recently a number of papers have appeared on the prognostic significance of cell kinetic parameters. The proliferative activity of tumour cells measured by thymidine labelling index (TLI) has been reported to have prognostic value in breast carcinomas (Meyer et al., 1984; Tubiana et al., 1984; Silvestrini et al., 1985) , and DNA ploidy and proliferative capacity (S-phase fraction) determined by flow cytometry have been found to be predictive of relapse-free and overall survival (Dressler et al., 1988; Kallioniemi et al., 1988) .
An important question is whether the aggressiveness of a cancer and the clinical course of the disease can be judged from the growth capacity of the cancer cells in vitro. Several earlier investigators have examined the relationship between colony forming ability of breast cancer cells in vitro and the survival of the patients (Sutherland et al., 1983; Hug et al., 1985; Dittrich et al., 1985; Aapro et al., 1987) . However, the results have been inconsistent and no clear conclusion has emerged. Since the previous studies often failed to address a clearly defined population and often involved a relatively small number of patients and short observation times, we have re-examined the issue on a substantially larger number of patients.
Materials and methods

Patients
Primary tumour specimens from a total number of 138 patients hospitalised in the Norwegian Radium Hospital during the years [1981] [1982] [1983] [1984] [1985] [1986] were evaluated for colony formation. All patients were females, with a mean age of 60 Courtenay & Mills (1978) , as previously described (Tveit et al., 1980 (Tveit et al., , 1984 . A total of 5 x 104 viable cells were plated per tube. The experiments were set up in triplicate. Colonies >60 gm in diameter were scored. Usually, the number of colonies per replicate tube were within + 20% of the mean. The plating efficiency (PE) was calculated as the number of colonies in percentage of the number of viable cells plated.
To rule out the possibility of pre-existing cell clumps two types of controls were used. In 62 of the tumours 10 pg ml-' of the toxin abrin was included, while in another 31 cases, a day 1 count of cultures without erythrocytes was performed. In none of these 93 cases were preculture clumps found that could be misinterpreted as colonies. Moreover, the colony formation was found to be closely similar in the two groups where controls were used, and in the 45 cases where controls were not included due to scarcity of cells.
Statistics
The difference in PEs between two groups was tested by Wilcoxon's rank sum test. Two-way frequency tables were Br. J. Cancer (1989), 60, 216-219 Cuthler & Ederer (1958) , and differences between survival curves were tested by the log rank test (Peto et al., 1977) . In patients who probably died of other diseases, the time of death was treated as censored observation in the survival analysis. The Cox proportional hazards model (Cox, 1972; Elashoff, 1983) was used to analyse the relative importance of several prognostic factors.
Stepwise analyses were performed and P values were estimated with the likelihood ratio test. The assumption of proportionality in the Cox model was tested with plot (Dixon, 1985) . All analyses were performed with the BMDPC computer programs (Dixon, 1985) .
Results
The relationship of the PEs of the primary tumours to various clinical and histopathological parameters are given in Table I .
Clinical and histopathological parameters Of the 138 primary tumours, 40 were from premenopausal and 98 from post-menopausal patients. The fraction of (Table I) .
Similar fractions of colony-forming tumours were found in ductal and non-ductal carcinomas (Table I) (Table I) .
The colony-forming ability, revealed as the fraction of colony-forming tumours and the median PE, was unaffected by T-status, N-status and M-status (Table I) .
In the present study, the fraction of tumours capable of in vitro growth was the same in the hormone receptor-positive and the receptor-negative groups (Table I ). The ER-negative tumours had higher median PEs than ER-positive tumours, while the opposite was found in the case of PgR. However, the differences were not statistically significant.
Survival
The median follow-up period was 74 months. The difference in crude survival between patients with tumours unable to (Figure 2 ). The number of involved nodes or the ER level did not differ significantly in the PE<0.1 and PE>0.1 groups of nodepositive patients.
A multivariate survival analysis was carried out on the 137 patients as well as on the 115 patients with primary tumours who had no distant metastases (67 node-positive and 48 node-negative). Plating efficiency competed with the known prognostic factors nodal status and ER status, tumour size and age. The best plot of the proportional hazards was obtained with PE<0.1. However, this grouped PE was not a significant prognostic factor in addition to nodal and ER status (Tables II and III) . The variables in the tables refer to the order in which they were entered in the multivariate analyses
Discussion
The main question raised here, whether the colony forming ability of tumour cells in soft agar is correlated with the prognosis of the patient, is of considerable general interest.
If the malignancy of a tumour could be predicted on the basis of an in vitro assay of its growth potential, this could have therapeutic implications.
Indications have previously been obtained by some authors that in vitro growth may be related to in vivo malignancy. Thus, Sutherland et al. (1983) found in a survival analysis restricted to stage IV patients that increasing colony count was associated with decreasing survival, and later Aapro et al. (1987) found a trend towards shorter time to relapse and death with increasing number of colonies, but there was no statistically significant correlation between colony forming ability and crude survival. In contrast, the present results, in general agreement with the findings of Dittrich et al. (1985) , showed no statistically significant difference between the survival of patients whose tumours failed to grow in vitro and those with growing tumours. Neither did we find any difference in relapse-free (Ottestad et al., 1988 ) that more breast carcinomas will grow in soft agar and higher PEs are obtained with the Courtenay-Mills assay than with the Hamburger-Salmon assay (Hamburger & Salmon, 1977) . However, the observed PEs are still low; in most cases no more than 10 out of 10,000 cells plated gave rise to colonies. Possibly, other culture conditions may select different cell populations, and other relationships between colony formation and clinical and histopathological parameters than found here might emerge. However, the difference between our results and those of Sutherland et al. (1983) and Aapro et al. (1987) can hardly be accounted for by the fact that different colony forming assays were used, since Dittrich et al. (1985) , like Sutherland et al. (1983) , used the H-S assay.
The lack of significant correlation between colony formation in vitro and the prognosis of the patients from whom the cells were derived emphasises the limitations of in vitro growth assays and the great importance of host factors for the clinical course of the disease. 
